Akebia Therapeutics (AKBA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Akebia Therapeutics (AKBA) over the last 10 years, with Q3 2025 value amounting to -$6.4 million.
- Akebia Therapeutics' Other Gross PP&E Adjustments rose 3892.62% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year increase of 3892.62%. This contributed to the annual value of -$9.7 million for FY2024, which is 4800.8% up from last year.
- As of Q3 2025, Akebia Therapeutics' Other Gross PP&E Adjustments stood at -$6.4 million, which was up 3892.62% from -$7.6 million recorded in Q2 2025.
- Akebia Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at -$6.4 million during Q3 2025, with a 5-year trough of -$32.6 million in Q1 2022.
- In the last 5 years, Akebia Therapeutics' Other Gross PP&E Adjustments had a median value of -$18.6 million in 2023 and averaged -$19.1 million.
- Per our database at Business Quant, Akebia Therapeutics' Other Gross PP&E Adjustments crashed by 3080.8% in 2022 and then soared by 5578.34% in 2023.
- Akebia Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$28.6 million in 2021, then increased by 19.86% to -$22.9 million in 2022, then grew by 18.93% to -$18.6 million in 2023, then soared by 48.01% to -$9.7 million in 2024, then surged by 34.13% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$7.6 million for Q2 2025, and -$8.1 million during Q1 2025.